Hillstream BioPharma Inc.

NASDAQ: HILS · Real-Time Price · USD
0.24
0.02 (7.00%)
At close: Sep 22, 2023, 9:59 PM

Hillstream BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021
Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Cash & Equivalents
2.69M 3.9M 3.57M 6.51M 7.6M 9.48M 11.12M 4.36K 45.09K 29.27K
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
477.89K 695.38K 1.15M 178.09K 235.95K 301.37K 233.18K 617.32K 3.87K 5.05K
Total Current Assets
3.17M 4.6M 4.72M 6.69M 7.83M 9.79M 11.36M 621.68K 414.89K 283.13K
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Assets
3.17M 4.6M 4.72M 6.69M 7.83M 9.79M 11.36M 621.68K 414.89K 283.13K
Account Payables
1.14M 1.14M 718.99K 954.5K 536.84K 559.53K 597.46K 1.46M 1.21M 1.04M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a 697.84K 658.43K 463.6K
Short-Term Debt
n/a n/a 559.92K n/a n/a n/a n/a 1.39M 1.22M 646.48K
Other Current Liabilities
271.33K 389.92K 242.22K 190.47K 179.87K 185.94K 418.88K 1.68M 3.53M 3.07M
Total Current Liabilities
1.41M 1.53M 1.52M 1.14M 716.71K 745.47K 1.02M 4.53M 6.63M 5.22M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a 772.9K 933.36K 1.36M
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 718.99K 954.5K 536.84K n/a n/a 772.9K 933.36K 1.36M
Total Liabilities
1.41M 1.53M 1.52M 1.14M 716.71K 745.47K 1.02M 5.31M 7.56M 6.58M
Total Debt
n/a n/a 559.92K n/a n/a n/a n/a 2.17M 2.15M 2.01M
Common Stock
1.76K 1.69K 1.16K 1.16K 1.16K 1.16K 1.14K 636.00 636.00 636.00
Retained Earnings
-22.23M -20.41M -18.07M -15.38M -13.62M -11.49M -9.85M -6.91M -9.36M -8.51M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity
1.76M 3.07M 3.2M 5.54M 7.12M 9.04M 10.34M -4.68M -7.14M -6.3M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a